Invictus RG’s Medidata Solutions, Inc. MDSO Stock Holding History

Invictus RG’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,039	Closed	-$233K	–	912
2017 Q1	$233K	Buy	+4,039	New	+$218K	0.16%	258

Other funds holding MDSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Invictus RG's MDSO Position: Q2 2017 in Review

Invictus RG sold out of Medidata Solutions, Inc. (MDSO) in Q2 2017, closing a stake of 4,039 shares — an estimated $233K sold.

Invictus RG first reported a position in MDSO in Q1 2017 and held it in 1 quarter. The position peaked at $233K in Q1 2017. 261 funds tracked by Wall St. Rank hold MDSO as of Q2 2017.

Invictus RG reported no remaining Medidata Solutions, Inc. position as of Q2 2017 after selling out during the quarter.
Invictus RG sold 4,039 Medidata Solutions, Inc. shares in Q2 2017, an estimated $233K.
Invictus RG first reported a position in Medidata Solutions, Inc. in Q1 2017 and held it in 1 quarter.
Invictus RG's Medidata Solutions, Inc. position peaked at $233K in Q1 2017.
261 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q2 2017.

Based on Invictus RG's 13F filing for Q2 2017, filed 14 Aug 2017.